Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
FDA/EMA/Drug Designation
In one of biotech’s hottest areas and with big partners like…
FDA/EMA/Drug Designation
CytoDyn Announces Execution of Exclusive Agreement with American Regent for Distribution…
Commercial
Rexgenero Appoints Dr Gilbert Wagener as Senior Vice President and Chief…
Commercial
Abivax treats first patient in Phase 2b/3 ABX464 Covid-19 clinical trial
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
FDA/EMA/Drug Designation
UK mulls joining EU coronavirus vaccines strategy – FirstWord Pharma
FDA/EMA/Drug Designation
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
FDA/EMA/Drug Designation
In one of biotech’s hottest areas and with big partners like…
FDA/EMA/Drug Designation
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
FDA/EMA/Drug Designation
Gilead’s Veklury gains conditional EU approval for treatment of COVID-19 –…
FDA/EMA/Drug Designation
The European Commission has Granted Orphan Medicinal Product Designation in the…
FDA/EMA/Drug Designation
Hydroxychloroquine found to significantly cut death rates in new COVID-19 study…
FDA/EMA/Drug Designation
Discovery of new step in how brain cells work could lead…
Home
Clinical
FDA/EMA/Drug Designation
FDA/EMA/Drug Designation
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
FDA/EMA/Drug Designation
Gilead’s Veklury gains conditional EU approval for treatment of COVID-19 – FirstWord Pharma
Firstwordpharma News
-
July 4, 2020
FDA/EMA/Drug Designation
The European Commission has Granted Orphan Medicinal Product Designation in the EU for MIV-818 – FirstWord Pharma
FDA/EMA/Drug Designation
COVID-19 vaccines to enter late-stage trial by end of July, Fauci says – FirstWord Pharma
FDA/EMA/Drug Designation
Hydroxychloroquine found to significantly cut death rates in new COVID-19 study – FirstWord Pharma
FDA/EMA/Drug Designation
Discovery of new step in how brain cells work could lead to new therapies for epilepsy – FirstWord Pharma
FDA/EMA/Drug Designation
UK mulls joining EU coronavirus vaccines strategy – FirstWord Pharma
Firstwordpharma News
-
July 4, 2020
0
FDA/EMA/Drug Designation
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Firstwordpharma News
-
July 4, 2020
0
FDA/EMA/Drug Designation
In one of biotech’s hottest areas and with big partners like...
Firstwordpharma News
-
July 4, 2020
0
FDA/EMA/Drug Designation
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Firstwordpharma News
-
July 4, 2020
0
FDA/EMA/Drug Designation
CytoDyn Announces Execution of Exclusive Agreement with American Regent for Distribution...
Firstwordpharma News
-
July 4, 2020
0
1
2
3
...
91
Page 1 of 91
- Advertisement -
MOST POPULAR
AbbVie Takes Top Spot in Best Place to Work Survey
April 9, 2019
UK, German cost-effectiveness bodies unconvinced by Bayer’s TRK inhibitor Vitrakvi
January 17, 2020
Possible new treatment strategy against progeria
November 18, 2019
Immunotherapy Appears Better Than Chemotherapy for Aggressive Type of Skin Cancer
February 7, 2019
Load more
HOT NEWS
Others
BioSpace Global Roundup, May 16
Approval
ERVEBO (Ebola Zaire Vaccine, Live) Now Registered in Four African Countries,...
Deals
Allele Biotechnology and SCM Lifescience Sign a Joint Research and Development...
Orphan-paediatric
Takeda, Microsoft and EURORDIS release report with action plan to help...
